These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 1091396)

  • 21. The effects of morphine, etorphine and sinomenine on the chemical sensitivity and synaptic responses of Renshaw cells and other spinal neurones in the rat.
    Lodge D; Headley PM; Duggan AW; Biscoe TJ
    Eur J Pharmacol; 1974 May; 26(2):277-84. PubMed ID: 4854802
    [No Abstract]   [Full Text] [Related]  

  • 22. Withdrawal tolerance and unidirectional non-cross-tolerance in narcotic pellet-implanted mice.
    Lange DG; Roerig SC; Fujimoto JM; Busse LW
    J Pharmacol Exp Ther; 1983 Jan; 224(1):13-20. PubMed ID: 6681541
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog.
    Martin WR; Eades CG; Thompson JA; Huppler RE; Gilbert PE
    J Pharmacol Exp Ther; 1976 Jun; 197(3):517-32. PubMed ID: 945347
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Etrophine in man. II. Detectability in urine by common screening methods.
    Gorodetzky CW; Kullberg MP
    Clin Pharmacol Ther; 1975 Mar; 17(3):273-6. PubMed ID: 1120393
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Opioid agonist and antagonist properties of diastereoisomeric N-tetrahydronoroxymorphones in mice.
    Ramabadran K; Jen MF
    Arch Int Pharmacodyn Ther; 1985 Apr; 274(2):180-8. PubMed ID: 4040738
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Narcotics and medical practice. Medical use of morphine and morphine-like drugs and management of persons dependent on them.
    JAMA; 1971 Oct; 218(4):578-83. PubMed ID: 5171009
    [No Abstract]   [Full Text] [Related]  

  • 27. Agonist and antagonist properties of buprenorphine, a new antinociceptive agent.
    Cowan A; Lewis JW; Macfarlane IR
    Br J Pharmacol; 1977 Aug; 60(4):537-45. PubMed ID: 409448
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influences of locus coeruleus lesions and reserpine treatment on opioid physical dependence in rats.
    Miao H; Qin BY
    Zhongguo Yao Li Xue Bao; 1995 Mar; 16(2):137-40. PubMed ID: 7597914
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analgesic effect of etorphine in rats with selective depletions of brain monoamines.
    Miranda F; Candelaresi G; Samanin R
    Psychopharmacology (Berl); 1978 Jun; 58(1):105-9. PubMed ID: 97714
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Abuse potential of zomepirac.
    Johnson RE; Jasinski DR; Kocher TR
    Clin Pharmacol Ther; 1983 Sep; 34(3):386-9. PubMed ID: 6883915
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Brain serotonin turnover in morphine tolerant and dependent mice.
    Shen FH; Loh HH; Way EL
    J Pharmacol Exp Ther; 1970 Nov; 175(2):427-34. PubMed ID: 5529726
    [No Abstract]   [Full Text] [Related]  

  • 32. Evaluation of tilidine for morphine-like subjective effects and euphoria.
    Jasinski DR; Preston KL
    Drug Alcohol Depend; 1986 Nov; 18(3):273-92. PubMed ID: 3803198
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Propranolol in the treatment of opiate dependence -- a controlled study.
    Jacob RG; Holmstrand J; Eriksson JH; Anggård E
    Psychopharmacologia; 1975; 41(1):71-3. PubMed ID: 1091940
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cholecystokinin octapeptide induces endogenous opioid-dependent anxiolytic effects in morphine-withdrawal rats.
    Wen D; Sun D; Zang G; Hao L; Liu X; Yu F; Ma C; Cong B
    Neuroscience; 2014 Sep; 277():14-25. PubMed ID: 24993476
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute physical dependence: time course and relation to human plasma morphine concentrations.
    June HL; Stitzer ML; Cone E
    Clin Pharmacol Ther; 1995 Mar; 57(3):270-80. PubMed ID: 7697945
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Physical dependence of dihydroetorphine in mice and monkeys (author's transl)].
    Huang M; Qin BY
    Zhongguo Yao Li Xue Bao; 1982 Jun; 3(2):81-4. PubMed ID: 6214153
    [No Abstract]   [Full Text] [Related]  

  • 37. The restraint of red kangaroos using etorphine-acepromazine and etorphine-methotrimeprazine mixtures.
    Wilson GR
    Aust Vet J; 1974 Oct; 50(10):454-8. PubMed ID: 4447529
    [No Abstract]   [Full Text] [Related]  

  • 38. Discriminative stimulus effects of morphine withdrawal in the dependent rat: suppression by opiate and nonopiate drugs.
    Holtzman SG
    J Pharmacol Exp Ther; 1985 Apr; 233(1):80-6. PubMed ID: 4039002
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Time series modeling of heroin and morphine drug action.
    Tschacher W; Haemmig R; Jacobshagen N
    Psychopharmacology (Berl); 2003 Jan; 165(2):188-93. PubMed ID: 12404073
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The actions of narcotic antagonists in morphine-dependent rhesus monkeys.
    Villarreal JE; Karbowski MG
    Adv Biochem Psychopharmacol; 1973; 8(0):273-89. PubMed ID: 4212386
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.